Loading…

Royal Philips has agreed to acquire The Spectranetics Corporation for $38.50 per share in cash, implying an enterprise value of approximately €1.9 billion. The acquisition will expand Philips' image-guided therapy business.
“Philips to acquire The Spectranetics Corporation to accelerate expansion in image-guided therapy devices to treat cardiac and peripheral vascular disease”philips.com
Summarized from public sources; check the original articles before acting on it.